BeStock  
Stocks › Biotechnology › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #2772Biotechnology
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership90.2%-15.92 pts vs. prior quarter
Institutions holding194+5 vs. prior quarter
Insider trades (recent)47 buys / 2 sellsNet buying
Short interest14.08% of floatDays to cover 6.5 · as of 30 Oct 2026
Short-sale volume share23.1%5-day average of daily volume

Short-sale volume as % of daily volume

10%19%28%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$3.83M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

+$440.7KSuper+$3.4MBig+$933.3KMid+$10.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.5% of shares outstanding.

Largest holders

  • EcoR1 Capital, LLC7.56%
  • TCG Crossover Management, LLC6.89%
  • BlackRock6.18%
  • Sirenia Capital Management LP5.94%
  • FMR4.89%
  • Affinity Asset Advisors, LLC4.84%
  • Trails Edge Capital Partners, LP3.60%
  • State Street Global Advisors3.60%

By investor type

  • Mutual Fund40.68%
  • Hedge Fund33.13%
  • VC/PE Fund8.91%
  • Public Company6.60%
  • Individual/Insider1.60%
  • Endowment Fund0.23%
  • Private Company0.20%
  • Sovereign Wealth Fund0.17%

Reported short interest has risen from 10.89% to 14.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +1,348,179 4.9%
Invesco Ltd. Mutual Fund 2026/Q3 +715,914 1.7%
BlackRock Mutual Fund 2026/Q3 +594,932 6.1%
EcoR1 Capital, LLC Hedge Fund 2026/Q3 +3,174,519 7.6%
TCG Crossover Management, LLC VC/PE Fund 2026/Q3 +2,895,304 6.9%
Sirenia Capital Management LP Mutual Fund 2026/Q3 +2,495,777 5.9%
FMR Mutual Fund 2026/Q3 +2,054,048 4.9%
Affinity Asset Advisors, LLC Hedge Fund 2026/Q3 +2,032,012 4.8%
BlackRock Mutual Fund 2026/Q3 +1,963,541 5.5%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,643,129 3.9%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +1,514,000 3.6%
State Street Global Advisors Mutual Fund 2026/Q3 +1,512,896 3.6%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,091,464 2.6%
Vestal Point Capital, LP Hedge Fund 2026/Q3 +1,013,000 2.4%
Woodline Partners LP Hedge Fund 2026/Q3 +917,176 2.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
31 Oct 2026 Ajim Tamboli Chief Financial Officer Other Derivative Acquisition +42,500 – 42,500
31 Oct 2026 Paul Lizzul Chief Medical Officer Other Derivative Acquisition +42,500 – 42,500
31 Oct 2026 Daniel Faga Chief Executive Officer Other Derivative Acquisition +136,000 – 136,000
31 Oct 2026 Benjamin Stone Chief Business Officer Other Derivative Acquisition +42,500 – 42,500
14 Sep 2026 John Orwin Independent Chairperson Derivative Exercise and Retained +1,300 – 17,995
1 Sep 2026 J. Ware Independent Director Derivative Exercise and Sale -39,265 $44.78 15,660
14 Aug 2026 Paul Lizzul Chief Medical Officer Other Derivative Acquisition +60,492 – 137,651
14 Aug 2026 Daniel Faga Chief Executive Officer Other Derivative Acquisition +193,575 – 440,485
14 Aug 2026 Benjamin Stone Chief Business Officer Other Derivative Acquisition +60,492 – 137,651
1 Aug 2026 Paul Lizzul Chief Medical Officer Other Derivative Acquisition +60,492 – 77,159
1 Aug 2026 Daniel Faga Chief Executive Officer Other Derivative Acquisition +193,576 – 387,156
1 Aug 2026 Benjamin Stone Chief Business Officer Other Derivative Acquisition +60,492 – 77,159
14 Jun 2026 John Orwin Independent Chairperson Derivative Exercise and Retained +6,030 – 16,695
14 Jun 2026 John Schmid Independent Director Derivative Exercise and Retained +6,030 – 37,652
14 Jun 2026 Dennis Fenton Independent Director Derivative Exercise and Retained +6,030 – 10,995
14 Jun 2026 Magda Marquet Independent Director Derivative Exercise and Retained +6,030 – 15,960
14 Jun 2026 J. Ware Independent Director Derivative Exercise and Retained +6,030 – 15,660
14 Jun 2026 Rita Jain Independent Director Derivative Exercise and Retained +7,330 – 19,194
11 May 2026 John Orwin Independent Chairperson Other Derivative Acquisition +2,500 – 2,500
11 May 2026 John Orwin Independent Chairperson Other Derivative Acquisition +7,000 $17.81 7,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,056,413 14.1% 6.5
15 Oct 2026 6,958,100 19.5% 4.8
30 Sep 2026 5,190,809 14.5% 6.2
15 Sep 2026 4,500,079 12.6% 7.5
31 Aug 2026 4,030,463 11.3% 7.2
14 Aug 2026 3,892,563 10.9% 6.8

Discussion

No comments yet — be the first to weigh in on TRAX.

Sign in to join the discussion.

Scroll to Top